Abstract:Background: The flavonoid baicalein, a historically used Chinese herbal medicine, shows a wide range of biological and pharmaceutical effects, among which its potent antitumor activity has raised great interest in recent years. However, the molecular mechanism involved in the antimetastatic effect of baicalein remains poorly understood. This study aimed to verify the inhibitory effects of baicalein on metastasis of MDA-MB-231 human breast cancer cells both in vitro and in vivo, as well as to investigate the related mechanisms.Methods: MTT assay was used to examine the inhibition of baicalein on proliferation of MDA-MB-231 cells. Wound healing assay and the in vitro invasion assay was carried out to investigate the effects of baicalein on migration and invasion of MDA-MB-231 cells, respectively. In order to explore the effects of baicalein on tumor metastasis in vivo, xenograft nude mouse model of MDA-MB-231 cells was established. Animals were randomly divided into four groups (control, therapy group, and low-dose and high-dose prevention group, n= 6), and treated with baicalein as designed. Following sacrifice, their lungs and livers were collected to examine the presence of metastases. qRT-PCR and Western blot were performed to study the effects of baicalein on expression of SATB1, EMT-related molecules, and Wnt/beta-catenin signaling components of MDA-MB-231 cells as well as the metastatic tissue. Effects of baicalein on the expression of target proteins in vivo were also analyzed by immunohistochemistry.Results: Our results indicated that baicalein suppressed proliferation, migration, and invasion of MDA-MB-231 cells in a time-and dose-dependent manner. Based on assays carried out in xenograft nude mouse model, we found that baicalein inhibited tumor metastasis in vivo. Furthermore, baicalein significantly decreased the expression of SATB1 in MDA-MB-231 cells. It suppressed the expression of vimentin and SNAIL while enhancing the expression of E-cadherin. Baicalein also downregulated the expression of Wnt1 and beta-catenin proteins and transcription level of Wnt/beta-catenin-targeted genes.Conclusion: Our results demonstrate that baicalein has the potential to suppress breast cancer metastasis, possibly by inhibition of EMT, which may be attributed to downregulation of both SATB1 and the Wnt/beta-catenin pathway. Taken together, baicalein may serve as a promising drug for metastasis treatment of breast cancer.

Inhibition Mechanism of Baicalein on the Lung Metastasis of Breast Cancer Cell in Vivo

Baicalein Suppresses Metastasis of Breast Cancer Cells by Inhibiting Emt Via Downregulation of Satb1 and Wnt/Beta-Catenin Pathway

Effect of Baicalein on the Expression of Satb1 in Human Breast Cancer Cells

Baicalein Inhibits The Invasion, Migration And Epithelial-Mesenchymal Transition Of Bgc-823 Cells Through Nf-Kappa B/Snail Signaling Pathway

Baicalein Suppress EMT of Breast Cancer by Mediating Tumor-Associated Macrophages Polarization.

Flavonoid Baicalein Suppresses Adhesion, Migration and Invasion of MDA-MB-231 Human Breast Cancer Cells

Antitumor Activity of Baicalein on the Mice Bearing U14 Cervical Cancer

Baicalein Inhibits Orthotopic Human Non-Small Cell Lung Cancer Xenografts Via Src/Id1 Pathway

Baicalin Inhibits the Metastasis of Highly Aggressive Breast Cancer Cells by Reversing Epithelial-to-mesenchymal Transition by Targeting Β-Catenin Signaling.

Baicalein Induces Apoptosis and Autophagy of Breast Cancer Cells Via Inhibiting PI3K/AKT Pathway in Vivo and Vitro.

Preliminary investigation on the mechanism of baicalein regulating the effects of Nischarin on invasion and apoptosis of human breast cancer cells MCF-7 through Wnt3α/β-catenin pathway

Study on Inhibition Effect and Mechanism of Baicalin on LTEP-A2 Cells in Lung Cancer Patients

Baicalein targets STMN1 to inhibit the progression of nasopharyngeal carcinoma via regulating the Wnt/β‐catenin pathway

Baicalein inhibits non‐small‐cell lung cancer invasion and metastasis by reducing ezrin tension in inflammation microenvironment

Baicalein Inhibits Growth of Cervical Carcinoma Via Inducing Apoptosis of Tumor Cells In Vivo

Betulinic acid impairs metastasis and reduces immunosuppressive cells in breast cancer models

Baicalein inhibits proliferation and migration of gastric cancer MGC-803 cells

Baicalein Inhibits The Invasion And Metastatic Capabilities Of Hepatocellular Carcinoma Cells Via Down-Regulation Of The Erk Pathway

Baicalein inhibits renal cancer cell growth and metastasis via ERK and p38 pathway

Baicalin Inhibits Breast Cancer Development Via Inhibiting I Kappa B Kinase Activation In Vitro And In Vivo

Baicalein suppresses vasculogenic mimicry through inhibiting RhoA/ROCK expression in lung cancer A549 cell line